Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial

INTRODUCTION: Treatment satisfaction in diabetes management is vital to achieving long-term clinical outcomes. This analysis evaluated treatment satisfaction among patients with type 2 diabetes (T2D) after 52 weeks of treatment with once-weekly tirzepatide (5, 10, and 15 mg) compared with dulaglutid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hitoshi, Oura, Tomonori, Takeuchi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597937/
https://www.ncbi.nlm.nih.gov/pubmed/37843771
http://dx.doi.org/10.1007/s13300-023-01485-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597937/
https://www.ncbi.nlm.nih.gov/pubmed/37843771
http://dx.doi.org/10.1007/s13300-023-01485-3

Ejemplares similares